SOBEGAPHARMA
Board
1 director, last change in 2023Director (not named in the articles)
appointed by deed of 13-12-2023
term without a fixed end
earlier manager, until 13-12-2023
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- Each director alonedeed of 13-12-2023
Mandates through the years
1 name, the dashed line is todayMAESEN Bertrand Gabriel André Ghislain
Director (not named in the articles)
Director (not named in the articles)
BoardEarliermandate already running before its first mention
Mandates as a list
- MAESEN Bertrand Gabriel André Ghislain
- Director (not named in the articles), appointed by deed of 13-12-2023, still in office
- Manager, until 13-12-2023
Control
Shareholder
ANDRE FOURMY
share not stated
This company
SOBEGAPHARMA
Equity €187,268
Profit €24,247 in 2025
Capital
- Contribution
- €6,200
- Source
- 2025 annual accounts
Articles of association
deed of 13-12-2023 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 1 director
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- “Moitié cédant et moitié acquéreurs au prorata actions acquises, héritiers et légataires non de plein droit actionnaires sollicitent agrément…”
Shareholders
2 ownersOwners 2
- ANDRE FOURMYnatural personSourceown accounts 30-06-2021share not stated
- BERTRAND MAESENnatural personSourceown accounts 30-06-2021share not stated